/ /

  • linkedin
  • Increase Font
  • Sharebar

    New devices make strides in pediatric glaucoma

    Innovations improve physicians’ ability to examine youths, facilitate difficult cases



    New devices for pediatric glaucoma surgery are becoming available that improve the ability to examine pediatric patients, perform surgeries more easily, and enhance treatment of difficult cases.


    Dr. Freedman

    Durham, NC—Technologies for pediatric patients with glaucoma are helping to improve ophthalmologists’ ability to examine these young patients, perform selected surgeries, and treat difficult cases.

    Still, such advances have been slow to progress over the years. There remains much room for the introduction of novel devices, according to Sharon F. Freedman, MD, who provided an overview of some of the many options.

    New devices for measuring IOP

    Dr. Freedman lauded rebound technology (Icare, Icare Finland) because there is no need to take patients to the operating room as often simply to check their IOP. Though both non-contact and rebound tonometry can be performed without topical anesthetic, rebound tonometry is more easily used to obtain a young child’s IOP in the office setting.

    “Our studies [using rebound tonometry] with the Icare and the Icare ONE—not yet approved for commercial use in the United States—demonstrated in about two-thirds of cooperative children with known or suspected glaucoma that the tonometers measured IOP within 3 mm of the IOP measured with the gold-standard Goldmann applanation tonometer,” said Dr. Freedman, professor of ophthalmology and pediatrics, Duke Eye Center, Durham, NC.

    “The Icare IOP measurements were usually higher than the Goldmann measurements by about 2 mm Hg, making rebound tonometry an excellent screening device,” she added.


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results